Illumina to sell cancer-test maker Grail after latest antitrust ruling
Illumina to sell cancer-test maker Grail after latest antitrust ruling
121
views
Illumina Inc. said Sunday it will sell its Grail unit, after a federal appeals court on Friday found the $7.1 billion acquisition in 2021 to be anticompetitive.
Illumina Inc. said Sunday it will sell its Grail unit, after a federal appeals court on Friday found the $7.1 billion acquisition in 2021 to be anticompetitive.

Comments

https://stocktradingwebsites.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!